PRELUDE CAPITAL MANAGEMENT, LLC - AEVI GENOMIC MEDICINE INC ownership

AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 49 filers reported holding AEVI GENOMIC MEDICINE INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AEVI GENOMIC MEDICINE INC
ValueSharesWeighting
Q3 2017$03000.00%
Other shareholders
AEVI GENOMIC MEDICINE INC shareholders Q3 2017
NameSharesValueWeighting ↓
Birchview Capital, LP 128,000$20,0000.01%
ARTHUR M. COHEN & ASSOCIATES, LLC 64,390$10,0000.00%
Verity Asset Management, Inc. 17,000$3,0000.00%
VANGUARD GROUP INC 1,252,050$201,0000.00%
Kistler-Tiffany Companies, LLC 690$00.00%
BNP PARIBAS FINANCIAL MARKETS 2$00.00%
BARCLAYS PLC 69$00.00%
OneDigital Investment Advisors LLC 31,110$4,0000.00%
BANK OF AMERICA CORP /DE/ 4,365$1,0000.00%
WELLS FARGO & COMPANY/MN 15,384$2,0000.00%
View complete list of AEVI GENOMIC MEDICINE INC shareholders